|
Report Date : |
13.09.2014 |
IDENTIFICATION DETAILS
|
Name : |
AMRIYA PHARMACEUTICAL INDUSTRIES SAE |
|
|
|
|
Registered Office : |
3A |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as on) : |
31.12.2013 |
|
|
|
|
Date of Incorporation : |
1984 |
|
|
|
|
Com. Reg. No.: |
112775, |
|
|
|
|
Legal Form : |
Egyptian Joint Stock Company |
|
|
|
|
Line of Business : |
Engaged in the manufacture and export of pharmaceuticals
and medical preparations with 109 preparations, for human use, as well as
specialty food and veterinary products. Subject’s range is produced under license of Synthelabo
(France) and Weimer (Germany). |
|
|
|
|
No. of Employees : |
1,680 |
RATING & COMMENTS
|
MIRA’s Rating : |
A |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
Status : |
Good |
|
Payment Behaviour : |
Regular |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – June 01, 2014
|
Country Name |
Previous Rating (31.03.2014) |
Current Rating (01.06.2014) |
|
Egypt |
B1 |
B2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low Risk |
A2 |
|
Moderate Low Risk |
B1 |
|
Moderate Risk |
B2 |
|
Moderate High Risk |
C1 |
|
High Risk |
C2 |
|
Very High Risk |
D |
EGYPT - ECONOMIC OVERVIEW
Occupying the northeast
corner of the African continent, Egypt is bisected by the highly fertile Nile
valley, where most economic activity takes place. Egypt's economy was highly
centralized during the rule of former President Gamal Abdel NASSER but opened
up considerably under former Presidents Anwar EL-SADAT and Mohamed Hosni
MUBARAK. Cairo from 2004 to 2008 aggressively pursued economic reforms to
attract foreign investment and facilitate growth. Poor living conditions
combined with limited job opportunities for the average Egyptian contribute to
public discontent. After unrest erupted in January 2011, the Egyptian
Government backtracked on economic reforms, drastically increasing social spending
to address public dissatisfaction, but political uncertainty at the same time
caused economic growth to slow significantly, reducing the government's
revenues. Tourism, manufacturing, and construction were among the hardest hit
sectors of the Egyptian economy, pushing up unemployment levels, and economic
growth remains slow amid political uncertainty, government transitions, unrest,
and cycles of violence. Cairo since 2011 has drawn down foreign exchange
reserves and depended on foreign assistance, particularly from Gulf countries,
to finance imports and energy products and prevent further devaluation of the
Egyptian pound, fearing higher inflation from a weaker currency
|
Source
: CIA |
Company Name : AMRIYA PHARMACEUTICAL INDUSTRIES
SAE
Country of Origin : Egypt
Legal Form :
Egyptian Joint Stock Company
Registration Date : 1984
Commercial
Registration Number : 112775,
Alexandria
Tax Card Number :
100-133-738
Issued Capital : £E
216,000,000
Paid up Capital : £E
216,000,000
Total Workforce : 1,680
Activities :
Manufacture and export of pharmaceuticals and medical preparations
Financial Condition : Good
Payments :
Nothing detrimental uncovered
Operating Trend : Steady
Person Interviewed : Ali Feteiha, Finance Manager
AMRIYA
PHARMACEUTICAL INDUSTRIES SAE
Street : 3A El Moaskar El Romany Street
Area : Rushdy,
Ramleh
PO Box : 111
Town : Alexandria
Country : Egypt
Telephone : (20-3) 5431799 / 5839950
Facsimile : (20-3) 5431799
/ 5830958
Email : info@amriyapharm.com
Subject operates
from a large suite of offices that are rented and located in the Central
Business Area of Alexandria.
Branch Office (s)
Location Description
·
Amreya
Alexandria
Tel:
(20-3) 4701001 / 4701146 / 4701150 / 4701151
Fax:
(20-3) 4701003 / 4701153
·
15 El Nozha Street Office
premises
Nasr
City
Cairo
Tel: (20-2) 4181821
·
3 Bahaa
El Din Street Office
premises
Smouha
Alexandria
Tel:
(20-3) 4206921
Fax:
(20-3) 4206920
Name Position
·
Dr Hassan Abbass Helmy Chairman
·
Dr Shereen Hassan Abbass Helmy Vice
Chairman
·
Yashar Hassan Abbass Director
·
Ahmed Amin Hassan Director
·
Adel Salah Tawfik Director
·
Said
Ahmed Khalil Director
·
Meawad
Abdallah Director
·
Tarek
Mohamed Osman Director
·
Abbass
El Gheriany Director
·
Ali Feteiha Finance Manager
·
Dr Yasser Fayed Sales
Manager
·
Dr
Essam Al Ansari Marketing
Manager
·
Hesham
Shaar IT
Manager
·
Mohab
Areby Human
Resources Manager
·
Ibrahim
Abd El Hamid Sharaf Import
Manager
Date of Establishment : 1984
Legal Form :
Egyptian Joint Stock
Company
Commercial Reg. No. : 112775,
Alexandria
Tax Card No. : 100-133-738
Authorised
Capital : £E 300,000,000
Issued Capital : £E 216,000,000
Paid up Capital : £E 216,000,000
·
Pharco
Pharmaceuticals Group 95.0%
Borg El Arab
Alexandria
Tel: (20-3) 4480130 / 4480140
Fax: (20-3) 4480730
·
Egyptian
European Pharmaceuticals Co (EEPI) 1.2%
Cairo
·
Local
businessmen and private investors 3.8%
·
European
Pharmaceutical Industries
Desert Road, Km 25
Elmanshia, Amriya
Alexandria
Tel: (20-3) 4701001
Fax: (20-3) 4701003
Email: sherien@pharco.com.eg
·
Safe
Pharma SAE
2nd Industrial Zone, Plot 2, Block 31, Area No. 3, New Borg El Arab
PO Box: 49, Sidi Gaber
Alexandria 21311
Tel: (20-3) 4592158 / 4592038 / 4592159 / 4592168
Fax: (20-3) 4592161
·
Islamic
Pharmaceuticals Chemicals & Medical Supplies Co SAE
496 El Horreya Road
Boulkley, Ramleh
PO Box: 12, Sidi Gaber
Alexandria
Tel: (20-3) 5823745 / 5821999 / 5839670 / 5863745
Fax: (20-3) 5830958
·
Pharco
B International
·
Techno
Pharma Egypt
·
Pharco
Impex 93 Srl
·
Abou
Kir Trading
Activities: Engaged in the manufacture and
export of pharmaceuticals and medical preparations with 109
preparations, for human use, as well as
specialty food and veterinary products.
Subject’s range is produced under license
of Synthelabo (France) and Weimer (Germany).
Subject is ISO 14001
and ISO 9001 accredited.
Import
Countries: Germany, France,
Japan, China and India
Export
Countries: Saudi
Arabia, Yemen, Libya, Sudan and Togo
Operating Trend: Steady
Subject has a
workforce of approximately 1,680 employees.
Financial
highlights provided by local sources are given below:
Currency: Egyptian
Pounds (£E)
Year
Ending 31/12/12: Year
Ending 31/12/13:
Total Sales £E 302,000,000 £E 310,000,000
Local sources consider
subject’s financial condition to be Good.
The above financial
figures are based on estimations by our local sources.
·
Citibank
95, 26th July Street
Azarita
Alexandria
Tel: (20-3) 4834363 / 4840342
Fax: (20-3) 4884363
·
Misr International
Bank (MIBANK)
33, Safia Zaghloul Street
Raml Station
Alexandria
Tel: (20-3) 4828174 / 4828213
Fax:
(20-3) 4838216
·
Commercial
International Bank (CIB)
61 Sultan Hussein Street
Alexandria
Tel: (20-3) 4824643 / 4834255
Fax: (20-3) 4832240
·
National
Societe Generale Bank
240 El Corniche Street
Roushdy, Ramleh
Alexandria
Tel: (20-3) 5452352
Fax: (20-3) 5455715
·
Barclays
Bank Egypt
11 Sherket Misr Street
Azarita
Alexandria
Tel: (20-3) 4831308
Fax: (20-3) 4861307
No complaints
regarding subject’s payments have been reported.
Credit amount 100,000
Amount overdue 0
Payment terms 60
days
Payment Method Letters
of Credit
Paying record No
Complaints
Currency US
Dollars
During the course
of this investigation nothing detrimental was uncovered regarding subject’s
operating history or the manner in which payments are fulfilled. As such the
company is considered to be a fair trade risk.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.60.84 |
|
|
1 |
Rs.98.72 |
|
Euro |
1 |
Rs.78.64 |
INFORMATION DETAILS
|
Analysis Done by
: |
DIV |
|
|
|
|
Report Prepared
by : |
PDT |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
|
-- |
NB |
New Business |
-- |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or
its officials.